Current Trials
EMERALD Pancreas
Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer
TebeMRD
A Phase II Non-Randomized, Open-label, Multi-centre Study of the Safety and Efficacy of Tebentafusp in Melanoma with Molecular Relapsed Disease
OxPLoreD
Oxford Pre-Cancerous Lymphoproliferative Disorders: Analysis and Interception study
WINGMEN
Windows trial of INsulin-like Growth factor neutralising antibody Xentuzumab in MEN scheduled for radical prostatectomy
SYMPLIFY
Observational study to assess a multi-cancer early detection test in individuals referred with signs and symptoms of cancer
CEeDD
CEeDD: Sonosensitive particles and ultrasound to enhance drug delivery in metastatic colorectal cancer
SCOOT
Sample Collection for The Integration and Analysis of Data Using Artificial Intelligence to Improve Patient Outcomes with Thoracic Diseases
IMP-MEL
IMP-MEL: IMM60 & pembrolizumab in Melanoma and NSCLC
ARCADIAN
ARCADIAN: Atovaquone with Radical ChemorADIotherapy in locally Advanced NSCLC
CEDAR
Chemoradiation with Enadenotucirev as a radiosensitiser in locally Advanced Rectal cancer
PanDox
PanDox: Targeted Doxorubicin in Pancreatic tumours
IPI-GLIO
Ipilimumab with Temozolomide versus Temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma
OCTOVA
Paclitaxel, olaparib and cediranib in platinum-resistant ovarian cancer.